Sort
8,912 grants matching “sars cov 2”
MiRNA-based Therapeutics for SARS-CoV-2 S1 mediated neuroinflammation and beta-amyloid production
$74,750Eleni Markoutsa · University Of South Florida · R03 · FY2023 · NS
MiRNA-based Therapeutics for SARS-CoV-2 S1 mediated neuroinflammation and beta-amyloid production
$74,750Eleni Markoutsa · University Of South Florida · R03 · FY2022 · NS
Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases
$74,688Matthew Scotch · Arizona State University-Tempe Campus · U01 · FY2020 · LM
Monogenic basis of resistance to SARS-CoV2 and predisposition to severe COVID-19
$74,534Jean-Laurent Casanova · Rockefeller University · R01 · FY2022 · AI
Designing addressable proteoliposomes by using viral transmembrane proteins and biomimetic cell-free synthesis techniques.
$74,284Ekaterina Selivanovitch · Cornell University · F32 · FY2024 · AI
Antiviral lung resident memory T cell maintenance and reinvigoration
$74,284Mariah A Hassert · University Of Iowa · F32 · FY2024 · AI
Elucidating the mechanisms of alphavirus subgenomic RNA translation
$74,284Kenneth Harold Dinnon · Rockefeller University · F32 · FY2024 · AI
Structure-guided design of protease-resistant, lipopeptide inhibitors of SARS-CoV-2
$73,828Ariel Jade Kuhn · University Of Wisconsin-Madison · F32 · FY2024 · AI
Effect of Alcohol Consumption on Molecular Risk Factors for SARS-CoV-2
$73,720Urszula T Iwaniec · Oregon State University · R01 · FY2020 · AA
RAPID: Collaborative Research: Immunological adaptations in bats to moderate the effect of coronavirus infection
$73,574Liliana M Davalos · Suny At Stony Brook · · FY2020 · BIO
Cationic Silyl-lipids for Enhanced Delivery of Anti-viral RNA Therapeutics
$73,558Annaliese Franz · University Of California At Davis · R03 · FY2022 · EB
The impact of social isolation on aging health in schizophrenia
$73,375Abraham Reichenberg · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · MH
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$73,280Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
The Southwest National Primate Research Center
$73,260Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2023 · OD
Role of the MHV S Protein Fc Receptor Activity in Immune Evasion in the CNS
$73,250Julian L Leibowitz · Texas A&M University Health Science Ctr · R03 · FY2008 · AI
Role of the MHV S Protein Fc Receptor Activity in Immune Evasion in the CNS
$73,250Julian L Leibowitz · Texas A&M University Health Science Ctr · R03 · FY2009 · AI
Detection of SARS-CoV-2 and characterization of SARS-CoV-2 S-gene in major companion and food animals
$73,194Jianfa Bai · Kansas State University · U18 · FY2023 · FD
RAPID Collaborative proposal: Spatial dynamics of COVID-19
$73,034John M Drake · University Of Georgia Research Foundation Inc · · FY2020 · BIO
Cytokine-mediated neurologic disease in COVID-19
$72,200Abigail Rose Vanderheiden · Washington University · F32 · FY2023 · NS
COVID Support from the IDPS to NIAID Investigators
$72,183William Elkins · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Screening for regulators of SARS CoV-2 infection and inflammation
$72,177Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
SARS-CoV-2 Immunology and Therapeutics
$72,116Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Nursing Home Environments and COVID Related Outcomes for Persons with Dementia
$72,072Migette Kaup · Kansas State University · R21 · FY2021 · AG
Identification of immunological predictors of COVID-19 clinical outcomes
$71,700Andrea Lisco · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Epidemiology, immunology, and evolution of SARS-CoV-2 and other coronaviruses before and during the COVID-19 pandemic
$71,625Leah Katzelnick · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI